The stockholder litigation is a routine disclosure challenge and is unlikely to block the merger. Monitor for any further shareholder lawsuits or regulatory delays ahead of the October 15 vote. The deal's completion remains the base case.
Price Chart
Executive Summary
Supernus filed a supplemental proxy statement to address stockholder litigation alleging disclosure deficiencies in the merger proxy. The supplement provides additional detail on Cantor Fitzgerald's financial analyses, including specific cash/debt figures and fully diluted share ranges, but does not change the merger terms or the October 15 special meeting date. The litigation is procedural and unlikely to block the deal, but it introduces a modest risk of delay.
Key Financial Metrics
Key Facts
- Supernus received demand letters and two complaints alleging disclosure deficiencies in the merger proxy statement.
- Supernus and Indivior voluntarily supplemented the proxy statement with additional detail on Cantor Fitzgerald's financial analyses, without admitting liability.
- The special meeting of Supernus stockholders remains scheduled for October 15, 2026.
- Supplemental disclosures include Supernus's estimated cash of ~$372 million and debt of $0, and Indivior's estimated cash of ~$249 million and debt of ~$500 million.
- Cantor's DCF analysis for Supernus implied a per-share equity value range of $50.55 to $59.50.
- Cantor's DCF analysis for Indivior implied a dividend-adjusted per-share equity value range of $24.20 to $43.90.
Financial Impact
No change to deal value or terms; supplemental disclosures provide additional detail on financial advisor analyses.
Risk Factors
- Stockholder litigation could delay the merger or result in additional disclosure requirements.
- Failure to obtain required stockholder approvals at the October 15 special meeting.
- Regulatory approvals or other conditions to closing may not be satisfied.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001104659-26-113884 |
| Document: 0001104659-26-113884-index-headers.html | 0001104659-26-113884 |
| Document: 0001104659-26-113884-index.html | 0001104659-26-113884 |
| Document: 0001104659-26-113884.txt | 0001104659-26-113884 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 2d ago | 8-K | $40.96 | awaiting T+5 | awaiting T+5 | $41.59 (+1.54%) |
Oct 26, 2026 3d ago | Court Ruling | $40.96 | awaiting T+5 | awaiting T+5 | $41.59 (−1.54%) |
Oct 21, 2026 7d ago | 8-K | $42.07 | awaiting T+5 | awaiting T+5 | $41.59 (−1.14%) |
Oct 19, 2026 9d ago | 8-K | $41.23 $40.54 | ▼ −1.67% | ▼ −1.70% | $41.59 (+0.87%) |
Oct 19, 2026 10d ago | Press Release | $39.84 $40.63 | ▲ +1.98% | ▲ +2.13% | $41.59 (+4.39%) |
Oct 6, 2026 23d ago | 425 | $42.83 $42.01 | ▼ −1.91% | ▼ −1.78% | $41.59 (−2.90%) |
Oct 6, 2026 23d ago | DEFA14A | $42.83 $42.01 | ▼ −1.91% | ▼ −1.78% | $41.59 (−2.90%) |
Sep 11, 2026 6w ago | DEFM14A | $41.49 $42.78 | ▲ +3.11% | ▲ +3.00% | $41.59 (+0.24%) |
Aug 3, 2026 12w ago | DEFA14A / 425 | $43.25 $46.88 | ▲ +8.39% | ▲ +8.49% | $41.59 (−3.84%) |
Aug 3, 2026 12w ago | 8-K | $43.25 $46.88 | ▲ +8.39% | ▲ +8.49% | $41.59 (−3.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers